Translational Regenerative Medicines - Global Market Outlook (2022-2028)
According to Stratistics MRC, the Global Translational Regenerative Medicines Market is growing at a CAGR of 13.9% from 2017 to 2026. Factors such as the increasing prevalence of degenerative diseases, rise in aging population and growing advancements in developed countries are the major driving factors. However, ethical concerns related to the use of embryonic stem cells in research & development hinders market growth.
Regenerative medicine is a segment of translational research in molecular biology and tissue engineering. It involves the process of regeneration of human cells, tissues, or organs to re-establish their normal functions through stimulation of the body’s repair system. They are widely used in the treatment of many degenerative disorders occurring in the areas of dermatology, orthopedic, cardiovascular and neurodegenerative diseases.
By Product Type, the Gene therapy segment is expected to have significant growth during the forecast period. Gene therapy assists the foundation for innovative treatments of innumerable musculoskeletal disorders. By geography, North America dominated the global regenerative medicine market owing to an increased number of leading companies and growth in the expansion of research and development activities in the U.S.
Some of the key players profiled in the Translational Regenerative Medicines Market include Vericel Corporation, Gamida Cell Ltd., Athersys, Inc., Orthofix International N.V, Anika Therapeutics, Novartis, Celgene Corporation, Brainstorm Cell Therapeutics Inc., Nuvasive, Inc., and Medipost.
Product Types Covered:
• Cell-Based Products
• Tissue Engineered Products
• Gene Therapy Products
Applications Covered:
• Dermatology
• Cardiovascular
• Oncology
• Diabetes
• Orthopedic
• Neurology
• Other Applications
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, , and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Translational Regenerative Medicines Market, By Product Type
5.1 Introduction
5.2 Cellular
5.3 Acellular
6 Global Translational Regenerative Medicines Market, By Therapy
6.1 Introduction
6.2 Gene Therapy
6.3 Cell Therapy
6.4 Immunotherapy
6.5 Tissue Engineering
7 Global Translational Regenerative Medicines Market, By Application
7.1 Introduction
7.2 Dermatology
7.3 Cardiovascular
7.4 Oncology
7.5 Diabetes
7.6 Orthopedic
7.7 Neurology
7.8 Other Applications
8 Global Translational Regenerative Medicines Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Vericel Corporation
10.2 Gamida Cell Ltd.
10.3 Athersys, Inc.
10.4 Orthofix International N.V
10.5 Anika Therapeutics
10.6 Novartis
10.7 Celgene Corporation
10.8 Brainstorm Cell Therapeutics Inc.
10.9 Nuvasive, Inc.
10.10 Medipost
List of Tables
Table 1 Global Translational Regenerative Medicines Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
Table 3 Global Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
Table 4 Global Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
Table 5 Global Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
Table 6 Global Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
Table 7 Global Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
Table 8 Global Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
Table 9 Global Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
Table 10 Global Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
Table 11 Global Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
Table 12 Global Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
Table 13 Global Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
Table 14 Global Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
Table 15 Global Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
Table 16 Global Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
Table 17 Global Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
Table 18 North America Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
Table 19 North America Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
Table 20 North America Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
Table 21 North America Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
Table 22 North America Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
Table 23 North America Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
Table 24 North America Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
Table 25 North America Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
Table 26 North America Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
Table 27 North America Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
Table 28 North America Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
Table 29 North America Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
Table 30 North America Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
Table 31 North America Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
Table 32 North America Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
Table 33 North America Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
Table 34 North America Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
Table 35 Europe Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
Table 36 Europe Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
Table 37 Europe Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
Table 38 Europe Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
Table 39 Europe Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
Table 40 Europe Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
Table 41 Europe Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
Table 42 Europe Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
Table 43 Europe Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
Table 44 Europe Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
Table 45 Europe Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
Table 46 Europe Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
Table 47 Europe Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
Table 48 Europe Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
Table 49 Europe Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
Table 50 Europe Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
Table 51 Europe Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
Table 52 Asia Pacific Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
Table 53 Asia Pacific Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
Table 54 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
Table 55 Asia Pacific Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
Table 56 Asia Pacific Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
Table 57 Asia Pacific Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
Table 58 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
Table 59 Asia Pacific Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
Table 60 Asia Pacific Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
Table 61 Asia Pacific Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
Table 62 Asia Pacific Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
Table 63 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
Table 64 Asia Pacific Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
Table 65 Asia Pacific Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
Table 66 Asia Pacific Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
Table 67 Asia Pacific Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
Table 68 Asia Pacific Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
Table 69 South America Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
Table 70 South America Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
Table 71 South America Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
Table 72 South America Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
Table 73 South America Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
Table 74 South America Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
Table 75 South America Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
Table 76 South America Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
Table 77 South America Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
Table 78 South America Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
Table 79 South America Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
Table 80 South America Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
Table 81 South America Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
Table 82 South America Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
Table 83 South America Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
Table 84 South America Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
Table 85 South America Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
Table 86 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
Table 87 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
Table 88 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
Table 89 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
Table 90 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
Table 91 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
Table 92 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
Table 93 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
Table 94 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
Table 95 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
Table 96 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
Table 97 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
Table 98 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
Table 99 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
Table 100 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
Table 101 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
Table 102 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
Research Methodology
The research study released with title "Translational Regenerative Medicines - Global Market Outlook (2022-2028)" involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Key Executives Interviewed
Research Programs/Design
| Historical Data (2017-2022E) |
|
|
| Market Factor Analysis |
|
|
| Market Forecast (2023F-2028F) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate and estimate the global/regional market size by manufacturers, regional splits, product segments and application.
To establish Research coverage of the study with most relevant & functional players HTF MI follows industry standards such as NAICS/SIC/ICB/TRCB, furthermore the sorted list of companies is validated using Product Mapping and business activities and shortlisted by industry perspective.
HTF MI select experienced analyst and associate that are specialized in the domain for conducting research. They prepare a list of companies by region that helps to understand players penetration rate in the market. This companies are further analyses in what segment or application they serve in our market. The list of product and applications are evaluated for each companies dealing in the Translational Regenerative Medicines Global Market Outlook. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global. Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Online) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc from Translational Regenerative Medicines Global Market Outlook who then work towards appointment generation.
Primary Data Collection
The primary research is performed by taking the interviews of executives of various companies dealing in the Translational Regenerative Medicines Global Market Outlook as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and relevant list of appointee or target primary respondents; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & In Mail, Community Forums, Open Survey, SurveyMonkey etc.
Secondary Sources
The secondary resources considered in the Translational Regenerative Medicines Global Market Outlook study includes company annual reports, press releases, published articles of organizations and associations, and the survey taken through different mediums such as online website and forums, survey monkey, LinkedIn, etc. In addition, the valuable strategic information obtained from industry association, paid database, and investor presentations are also good tool for information to make appropriate iterative validation are used to modify market models and cross-verify primary research and insights.
Market Breakdown and Data Triangulation
To make market engineering data complete; extensive primary research is conducted to gather information and validate the critical numbers derived to be used for calculations of market statistics; market size estimations; forecasting; breakdown; and data triangulation. Both top-down and bottom-up approaches were applied, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Furthermore qualitative and further quantitative analysis is also done for all the numbers arrived at in the market estimation process to list relevant information in the final deliverable report "Translational Regenerative Medicines - Global Market Outlook (2022-2028)" .
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Key Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments |
|
|
| Total Market |
|
|
| Format | Properties | |
|---|---|---|
| 1-User Access | The report is sent in PDF format. The report will be emailed to you. | This is a single user access license, allowing one specific user to access the report. |
| Site User | The study would be provided in PDF format. The report will be emailed to you. | This is a site license, allowing 1-10 employees within your organisation to access the report. |
| Enterprise User | The format of deliverable would be PDF and Excel. | This is an enterprise or corporate license, allowing all employees within your organisation irrespective of geographic location to access the report. |
